ASSESSMENT OF AWARENESS ABOUT A PRE-EXPOSURE PROPHYLAXIS PROCEDURE IN HIV-INFECTED PATIENTS, THEIR ATTITUDE TOWARDS ITS IMPLEMENTATION, AND PROSPECTS FOR ITS APPLICATION IN RUSSIA


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective. To study the awareness of Russian HIV-infected patients about a pre-exposure prophylaxis (PrEP) procedure and the assessments of prospects for its application and to clarify their attitude to the latter. Materials and methods. The study enrolled 96 patients infected with HIV. The investigators used a semistructured interview that included indicators as open and closed questions, the answers to which could clarify the sociodemographic characteristics of the study participants and their awareness about prevention of HIV transmission. Results. At the time of the interview, 61% of the respondents were unaware of the existence of the PrEP method. 16% ofthe respondents having discordant partners noted that they did not use HIV prevention methods. Most (77%) of the respondents expressed a positive attitude to the PrEP procedure; 10% reported that they did not think about this. 47, 29, and 24% assessed PrEP positively, doubtfully, and negatively respectively. The Internet was a primary source of information on PrEP for respondents; only 8% learned about the method from health workers. Conclusion. It is advisable to monitor the risk of HIV transmission, by assessing the time course of changes in the characteristics of the risk behavior of patients who are followed up and receive ART. Emphasizing the cause-and-effect relationship between adherence to physician recommendations and a lower risk of HIV transmission during adherence counseling enhances the ability to shape a desirable behavior in patients. To promote this prevention method, it is necessary to elaborate a PtEP algorithm, in the structure of which a significant place should be given to information and advice on reducing the risk of HIV transmission.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

Oksana EFREMOVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ks517@yandex.ru
Cand. Med. Sci., Researcher Moscow, Russia

Valentina BELYAEVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: labora-et-ora@yandex.ru
MD, Leading Researcher Moscow, Russia

Nadezhda KOZYRINA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Researcher Moscow, Russia

Ulyana KUIMOVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher Moscow, Russia

Anastasia POKROVSKAYA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: pokrovskaya_ av@mail.ru
Cand. Med. Sci., Senior Researcher Moscow, Russia

Zoya SUVOROVA

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: zksu@inbox.ru
Cand. Med. Sci., Senior Researcher Moscow, Russia

Әдебиет тізімі

  1. Building on the PrEP victory. Lancet. https://doi.org/10.1016/ S0140-6736(20)30688-7
  2. Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г., Шахгильдян В.И., Козырина Н.В., Буравцова Е.Е., Нарсия Р.С., Покровская А.В., Ефремова О.С., Коннов В.В., Куимова У.А., Попова А.А., Хохлова О.Н., Воронин Е.Е., Афонина Л.Ю., Васильева И.А., Зимина В.Н. Рекомендации по лечению ВИЧ-инфекции и связанных с ней заболеваний, химиопрофилактике заражения ВИЧ. Эпидемиол. инфекц. болезни. Актуал. вопр. 2018; (4, приложение). 80 с. https://epidemiology-journal.ru/ru/archive/ edition/9974
  3. Grant R.M., Lama J.R., Anderson P.L., McMahan V., Liu A.Y., Vargas L. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 2010; 363(27): 2587-99.
  4. Dolling D., Desai M., Saunders J., Mackie N.E., Mcowan A., Elaney Y. et al. Who accesses PrEP? An analysis of baseline data in the PROUD pilot study. Third joint BHIVA/BASHH Conference. Liverpool, 2014. Аbstract 043. https://www.bhiva. org/file/IkrpDWCVFvuAf/AbstractBook2014.pdf
  5. McCormack S., Dunn D. Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study. 2015. Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, USA, 2015. Аbstract 22LB. https://www. croiconference.org/abstract/pragmatic-open-label-randomised-trial-preexposure-prophylaxis-proud-study/
  6. Molina J-M. Spire B., Pialoux G., Chidiac C. et al. On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial. Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, USA, 2015. Аbstract 23LB. https://www.croiconference.org/abstract/demand-prep-oral-tdf-ftc-msm-results-anrs-ipergay-trial/
  7. Thigpen M., Kebaabetswe P.M., Smith D.K., Segolodi T. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Rome, 2011. Аbstract WELBC01. https://library.iasociety.org/Media View. aspx?media_id=4703
  8. Baeten J., Heffron R., Kidoguchi L., Celum C. Near elimination of HIV transmission in a demonstration project of PrEP and ART. Conference on Retroviruses and Opportunistic Infections. Seattle, WA, USA, 23-26 February 2015. https://www. croiconference.org/abstract/near-elimination-hiv-transmission-demonstration-project-prep-and-art/
  9. Choopanya K., Vanichseni S., Suntharasamai P., Martin M. et al. The Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis trial in Thailand: participant adherence and study results.7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala Lumpur, 2013. Аbstract WELBC05. http://www.aidsmap.com/news/jul-2013/bangkok-prep-study-finds-prep-efficacy-related-drug-exposure
  10. Edelstein Z., Scanlin K., Findlater C., Salcuni P., Daskalakis D., Myers А. HIV Prevention Continuum among MSM, New York City, spring 2016. J. IAPAC 2017; Miami, FL Oral #27. https://www.iapac.org/Adherence Conference/ presentations/ADH 2017_OA270rev.pdf
  11. Козырина Н.В., Беляева В.В., Хохлова О.Н., Суворова З.К., Оганесян Э.Э., Манукян Ю.А., Атаманчук А.А., Светогор Т.Н., Тойтукова М.М., Тостоков Э.Т., Мустафаева Д.А., Бекметова М.Ю., Исмаилова Н.К., Шомахмудова Ш.Ш., Аловутдинова Н.А. Методы контрацепции, используемые женщинами, живущими с ВИЧ, в 5 странах СНГ. Материалы международной научно-практической конференции «Актуальные вопросы ВИЧ-инфекции».10-11 июня 2019, Санкт-Петербург. СПб, 2019; 282-3. https://congress-ph.ru/common/ htdocs/upload/ fm/vich/19/tezis.pdf
  12. Доконтактная профилактика (ДКП) в Восточной Европе и Центральной Азии: первые уроки. ЕСОМ, 2019. https:// docs.google.com/ viewerng/ viewer? url=https://ecom.ngo/ wp-content/uploads/2020/03/PrEP-Case-tudies _Report_RU. pdf&hl=ru

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2020

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>